Saturday 17 October 2026 Export AMS’s income statement to Excel — free account

American Shared Hospital Services

American Shared Hospital Services' revenue for fiscal 2025 (year ended December 2025) was $28.1 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 19.2%, EPS fell 75.0%, free cash flow grew 195.8% and total debt fell 32.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.

1.28 0.02 +1.59%

Follow AMS

Alert me

Market cap: $8.4M
P/E: 0.0×
Fwd P/E: 1.8×
Dividend yield: —
F-score: 3/9
Altman Z: 0.67
Beneish M: −2.06
Dividend safety: 10/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 1.34

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	1	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 35.83%

Capital & Financial Ratios $m

Market Cap 8.38

Revenue 30.41

Net Income (3.30)

Free Cash Flow 3.54

Net Debt 9.46

Current Ratio 0.77

Debt/Equity 0.63

P/E ratio 0.00

Fwd P/E 1.80

P/S ratio 0.29

P/B ratio 0.34

Past 5Y EPS Growth —

This Y EPS Growth 39.13%

Next Y EPS Growth (43.40%)

Next Y revenue growth 55.16%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.18%

10-year low 10-year high

P/B against its own 10 years 3.06%

10-year low 10-year high

EV/Sales against its own 10 years 12.09%

10-year low 10-year high

EV/FCF against its own 10 years 96.55%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	14	11	4	7
Receivables	5	12	12	9
Inventory	—	—	—	—
Other	—	—	—	—
	20	26	18	17

	2023	2024	2025	Q'26
Payables	0	2	1	1
ST’ Debt	5	3	17	16
Other	3	4	4	3
	11	10	23	22

Compound Annual Growth %

	10y	5y	3y
Sales	5.43%	9.50%	12.46%
Cash Flow	(9.65%)	(20.48%)	(24.63%)
Earnings	0.00%	0.00%	0.00%
Book Value	0.96%	3.21%	2.62%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	7	8	—	—	—
’25	6	7	7	8	28
’24	5	7	7	9	28
’23	5	6	5	6	21
’22	5	5	5	5	20
’21	4	4	4	5	18
’20	5	4	5	5	18

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	2	2	—	—	—
’25	3	0	2	(1)	3
’24	(2)	1	0	0	0
’23	2	3	4	(3)	6
’22	0	4	2	2	7
’21	3	1	(1)	3	6
’20	3	3	1	2	10

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	2	2	—	—	—
’25	(2)	(2)	(2)	1	(5)
’24	(3)	0	0	(4)	(7)
’23	2	1	0	(3)	(1)
’22	0	4	1	2	7
’21	2	2	(1)	2	5
’20	3	3	1	2	9

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.09)	(0.07)	—	—	—
’25	(0.10)	(0.04)	0.00	(0.09)	(0.23)
’24	0.02	0.55	(0.03)	(0.20)	0.33
’23	0.03	(0.02)	0.02	0.06	0.10
’22	0.04	0.08	0.05	0.04	0.21
’21	0.00	(0.01)	0.01	0.04	0.03
’20	(0.02)	(0.08)	(0.03)	(1.01)	(1.14)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	1.51	2.45	2.19	2.30	1.16	2.03	2.08	2.16	2.37	2.01	Analyst estimates 2026–2028 Powerpack
	High	3.50	5.00	3.95	3.30	3.58	5.04	3.10	3.75	4.60	3.26
People
People	Employees	9	9	9	9	10	9	11	13	44	46
	Revenue/emp, $m	2.08	2.17	2.19	2.29	1.78	1.96	1.80	1.64	0.64	0.61
Income, $m
Income, $m	Revenue	19	20	20	21	18	18	20	21	28	28
	Gross margin, %	47.03	44.30	37.97	33.58	25.04	38.16	42.45	43.82	32.41	18.03
	EBT	3	2	2	2	(9)	1	3	1	1	(3)
	EBT margin, %	17.07	9.39	10.56	7.56	(53.00)	5.37	12.75	3.26	4.36	(11.47)
	Net income	2	3	2	1	(8)	1	2	0	2	(3)
	Depreciation	6	7	7	7	7	5	5	5	6	6
Per share, $
Per share, $	Revenue	3.36	3.40	3.38	3.48	2.89	2.92	3.14	3.35	4.36	4.24
	Earnings	0.17	0.33	0.18	0.11	(1.14)	0.03	0.21	0.10	0.34	(0.23)
	Cash flow	1.50	1.36	1.38	1.36	1.58	1.04	1.15	0.90	0.03	0.47
	Capex	(0.19)	(0.11)	(0.27)	(0.17)	(0.05)	(0.28)	(0.06)	(0.99)	(1.18)	(1.15)
	Free cash flow	1.32	1.25	1.11	1.19	1.53	0.76	1.09	(0.09)	(1.15)	(0.69)
	Book value	4.88	5.19	5.32	5.37	3.83	4.01	4.07	4.13	4.62	4.19
	Shares, m	6	6	6	6	6	6	6	6	6	7
Valuation, ×
Valuation, ×	P/E	20.00	7.73	13.22	20.33	0.00	59.25	14.00	26.67	9.11	0.00
	P/S	1.01	0.75	0.70	0.70	0.77	0.81	0.94	0.72	0.73	0.50
	P/B	0.70	0.49	0.45	0.45	0.58	0.59	0.72	0.58	0.69	0.50
	EV/Sales	2.03	1.56	0.89	0.82	0.95	1.24	0.99	0.80	1.05	1.29
	EV/FCF	5.18	4.24	2.71	2.40	1.80	4.75	2.85	(30.77)	(3.96)	(7.97)
Cash, $m
Cash, $m	Operating cash flow	8	8	8	8	10	6	7	6	0	3
	Capex	(1)	(1)	(2)	(1)	0	(2)	0	(6)	(8)	(8)
	Free cash flow	7	7	6	7	9	5	7	(1)	(7)	(5)
Balance, $m
Balance, $m	Working capital	(1)	0	0	3	(2)	9	14	10	16	(6)
	Total debt	22	18	5	4	8	16	13	16	20	17
	Net debt	19	16	4	3	3	8	1	2	9	14
	Shareholders’ equity	27	30	31	32	24	24	26	26	30	28
Returns, %
Returns, %	ROA	1.62	3.24	1.77	1.18	(14.49)	0.44	2.97	1.32	4.03	(2.69)
	ROIC	4.44	3.30	3.35	2.81	(21.99)	2.66	5.70	0.60	(4.50)	(5.43)
	ROE	3.55	6.74	3.36	2.10	(25.45)	0.81	5.33	2.35	7.76	(5.38)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CCEL Cryo-Cell International Inc.	$29.4M	— (loss-making)	43.8×	−0.02% (below 0%: shrinking)	+77.78% (above 0%: growing)	−58.37% (below 0%: shrinking)	79.38%	28.04%	Compare
DCGO DocGo Inc.	$27.9M	— (loss-making)	— (loss-making)	−8.70% (below 0%: shrinking)	n/m	−132.28% (below 0%: shrinking)	30.52%	(24.41%)	Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR	$15.9M	— (loss-making)	8.3×	+25,427.42% (above 0%: growing)	n/m	−206.36% (below 0%: shrinking)	42.70%	(1.24%)	Compare
CCM Concord Medical Services Holdings Limited	$10.5M	— (loss-making)	— (loss-making)	+37.65% (above 0%: growing)	n/m	−281.45% (below 0%: shrinking)	(13.15%)	0.00%	Compare
AMS American Shared Hospital Services	$8.4M	— (loss-making)	1.8×	+19.22% (above 0%: growing)	n/m	+195.82% (above 0%: growing)	17.00%	(7.22%)
CANOQ Cano Health, Inc.	$6.6M	— (loss-making)	—	−21.05% (below 0%: shrinking)	n/m	−43.68% (below 0%: shrinking)	100.00%	(16.23%)	Compare
MODVQ ModivCare Inc.	$6.2M	— (loss-making)	— (loss-making)	−3.18% (below 0%: shrinking)	n/m	−3,767.70% (below 0%: shrinking)	14.06%	(1.78%)	Compare
BMGL Basel Medical Group Ltd	$6.2M	—	—	—	—	—	—	—	Compare
RHEP Adcare Health Systems Inc	$5.2M	0.6×	— (loss-making)	+143.03% (above 0%: growing)	n/m	+224.45% (above 0%: growing)	31.50%	(0.88%)	Compare
Median of peers	$8.5M	—	—	−0.02%	—	−132.28%	31.50%	(1.24%)

All 55 Medical Care Facilities stocks →

American Shared Hospital Services (AMS) key facts

Concern: American Shared Hospital Services' revenue for fiscal 2025 (year ended December 2025) was $28.1 million, down 0.91% from fiscal 2024.
Concern: American Shared Hospital Services reported a net loss of $2.7 million, or a loss of $0.23 per share, for fiscal 2025.
American Shared Hospital Services (AMS) is a Medical Care Facilities company in the Healthcare sector, listed on NYSE American.
As of October 16, 2026, AMS traded at $1.28, a market capitalization of $8.4 million.
Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.3× sales.
Return on equity was −5.38% and debt-to-equity 0.63.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 0.67 (distress zone) for fiscal 2025.